In the TME, if the early influx of CD8+ T cells fail to clear the tumor, the tumor cells expressing high levels of PD-L1 in response to inflammation will induce T-cell anergy and lead to decreased effector T-cell activity.16 This evidence concerns the gene CD8A and neoplasm.